Appl1 is dispensable for Akt signaling in vivo and mouse T-cell development

Genesis

Volumn 48, Issue 9, 2010, Pages 531-539

  Tan, Yinfei ^a   You, Huihong ^a,b   Coffey, Francis J ^a   Wiest, David L ^a   Testa, Joseph R ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Akt signaling; Glucose metabolism; Knockout mouse model; PI3 kinase; T cell development

Indexed keywords

ADAPTOR PROTEIN; APPL1 PROTEIN; DNA; GLUCOSE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MATURATION; CELL VIABILITY; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME SUBUNIT; EXON; FEMALE; GENE; GENETIC ANALYSIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; IN VIVO STUDY; INSULIN TOLERANCE TEST; KNOCKOUT MOUSE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMOCYTE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BLOTTING, WESTERN; BROMODEOXYURIDINE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; FLOW CYTOMETRY; GLUCOSE TOLERANCE TEST; GLYCOGEN SYNTHASE KINASE 3; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MICE; MICE, KNOCKOUT; ONCOGENE PROTEIN V-AKT; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; THYMUS GLAND;

DANIO RERIO; MURINAE; MUS;

EID: 77957377071     PISSN: 1526954X     EISSN: 1526968X     Source Type: Journal    
DOI: 10.1002/dvg.20657     Document Type: Article

References (26)

1. Bi L, Okabe I, Bernard DJ, Nussbaum RL. 2002. Early embryonic lethality in mice deficient in the p110β catalytic subunit of PI 3-kinase. Mamm Genome 13:169-172.
2. Bi L, Okabe I, Bernard DJ, Wynshaw-Boris A, Nussbaum RL. 1999. Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110α subunit of phosphoinositide 3-kinase. J Biol Chem 274:10963-10968. (Pubitemid 129528301)
3. Cheng KK, Iglesias MA, Lam KS, Wang Y, Sweeney G, Zhu W, Vanhoutte PM, Kraegen EW, Xu A. 2009. APPL1 potentiates insulin-mediated inhibition of hepatic glucose production and alleviates diabetes via Akt activation in mice. Cell Metab 9:417-427.
4. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB III, Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ. 2001. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB b). Science 292:1728-1731.
5. Clark PR, Pober JS, Kluger MS. 2008. Knockdown of TNFR1 by the sense strand of an ICAM-1 siRNA: Dissection of an off-target effect. Nucleic Acids Res 36:1081-1097.
6. Fruman DA, Snapper SB, Yballe CM, Davidson L, Yu JY, Alt FW, Cantley LC. 1999. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85a. Science 283:393-397.
7. Habermann B. 2004. The BAR-domain family of proteins: A case of bending and binding? EMBO Rep 5:250-255.
8. He X, Kappes DJ. 2006. CD4/CD8 lineage commitment: Light at the end of the tunnel? Curr Opin Immunol 18:135-142.
9. Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, Mao M, Li B, Cavet G, Linsley PS. 2003. Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21:635-637.
10. Ko ML, Jian K, Shi L, Ko GY. 2009. Phosphatidylinositol 3 kinase-Akt signaling serves as a circadian output in the retina. J Neurochem 108:1607-1620.
11. Lauritsen JP, Wong GW, Lee SY, Lefebvre JM, Ciofani M, Rhodes M, Kappes DJ, Zuniga-Pflucker JC, Wiest DL. 2009. Marked induction of the helix-loop-helix protein Id3 promotes the gammadelta T cell fate and renders their functional maturation Notch independent. Immunity 31:565-575.
12. Liu J, Yao F, Wu R, Morgan M, Thorburn A, Finley RL Jr, Chen YQ. 2002. Mediation of the DCC apoptotic signal by DIP13 α. J Biol Chem 277:26281-26285.
13. Mao X, Kikani CK, Riojas RA, Langlais P, Wang L, Ramos FJ, Fang Q, Christ-Roberts CY, Hong JY, Kim RY, Liu F, Dong LQ. 2006. APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat Cell Biol 8:516-523.
14. Miaczynska M, Christoforidis S, Giner A, Shevchenko A, Uttenweiler- Joseph S, Habermann B, Wilm M, Parton RG, Zerial M. 2004. APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment. Cell 116:445-456. (Pubitemid 38366320)
15. Mitsuuchi Y, Johnson SW, Sonoda G, Tanno S, Golemis EA, Testa JR. 1999. Identification of a chromosome 3p14.3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein- serine/threonine kinase AKT2. Oncogene 18:4891-4898.
16. Oak JS, Deane JA, Kharas MG, Luo J, Lane TE, Cantley LC, Fruman DA. 2006. Sjogren's syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase. Proc Natl Acad Sci USA 103: 16882-16887.
17. Okkenhaug K, Bilancio A, Farjot G, Priddle H, Sancho S, Peskett E, Pearce W, Meek SE, Salpekar A, Waterfield MD, Smith AJ, Vanhaesebroeck B. 2002. Impaired B and T cell antigen receptor signaling in p110d PI 3-kinase mutant mice. Science 297:1031-1034. (Pubitemid 34856039)
18. Okkenhaug K, Vanhaesebroeck B. 2003. PI3K in lymphocyte development, differentiation and activation. Nat Rev Immunol 3:317-330.
19. Persengiev SP, Zhu X, Green MR. 2004. Nonspecific, concentration- dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA 10:12-18. (Pubitemid 38018731)
20. Saito T, Jones CC, Huang S, Czech MP, Pilch PF. 2007. The interaction of Akt with APPL1 is required for insulin-stimulated Glut4 translocation. J Biol Chem 282:32280-32287. (Pubitemid 350106472)
21. Sasaki T, Irie-Sasaki J, Jones RG, Oliveira-dos-Santos AJ, Stanford WL, Bolon B, Wakeham A, Itie A, Bouchard D, Kozieradzki I, Joza N, Mak TW, Ohashi PS, Suzuki A, Penninger JM. 2000. Function of PI3Kg in thymocyte development. T cell activation, and neutrophil migration. Science 287:1040-1046.
22. Scacheri PC, Rozenblatt-Rosen O, Caplen NJ, Wolfsberg TG, Umayam L, Lee JC, Hughes CM, Shanmugam KS, Bhattacharjee A, Meyerson M, Collins FS. 2004. Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc Natl Acad Sci USA 101:1892-1897.
23. Schenck A, Goto-Silva L, Collinet C, Rhinn M, Giner A, Habermann B, Brand M, Zerial M. 2008. The endosomal protein Appl1 mediates Akt substrate specificity and cell survival in vertebrate development. Cell 133:486-497.
24. Tan Y, You H, Wu C, Altomare DA, Testa JR. 2010. Appl1 is dispensable for mouse development, and loss of Appl1 has growth factor-selective effects on Akt signaling in murine embryonic fibroblasts. J Biol Chem 285:6377-6389.
25. Varsano T, Dong MQ, Niesman I, Gacula H, Lou X, Ma T, Testa JR, Yates JR III, Farquhar MG. 2006. GIPC is recruited by APPL to peripheral TrkA endosomes and regulates TrkA trafficking and signaling. Mol Cell Biol 26:8942-8952.
26. von Boehmer H, Fehling HJ. 1997. Structure and function of the pre-T cell receptor. Annu Rev Immunol 15:433-452. (Pubitemid 27169288)